SUBSCRIBE
SUBSCRIBE
News   Drug Development

BioSante Pharmaceuticals, Inc. To Present LibiGel(R) Safety Update at ENDO Annual Meeting

June 18, 2010 | 
1 min read
LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX), will present a LibiGel safety update at the 2010 Annual Meeting of the Endocrine Society (ENDO), being held from June 19-22, 2010 in San Diego, California.
Clinical research Phase 3
MORE ON THIS TOPIC
Illustration showing businessman trying to create his own road
FDA
Compass vows to press on with FDA application despite new trial request
September 22, 2026
 · 
3 min read
 · 
Annalee Armstrong
Changing or transforming, turning around, challenging the odds and conquering adversity, a businessman pole vaulting from the down arrow to the up arrow of growth
Obesity
Viking achieves ‘maintenance trifecta’ as GLP-1/GIP dual agonist exceeds expectations
September 22, 2026
 · 
3 min read
 · 
Heather McKenzie
Vector illustration representing kidney care, highlighting the importance of health and medical attention for these vital organs
Clinical research
Vertex opens up larger kidney disease opportunity with mid-stage readout
September 22, 2026
 · 
3 min read
 · 
Annalee Armstrong
Abstract falling drop of blood with white cubes of sugar inside. Diabetes symbol type1, 2. Low poly style design. Modern 3d concept. Blue geometric background. Wireframe connection structure. Vector
Diabetes
Roche’s Carmot asset normalizes blood sugar, cuts weight in Phase 2 diabetes trial
September 22, 2026
 · 
2 min read
 · 
Annalee Armstrong